Elanco Animal Health Inc (ELAN)
13.36
-0.04
(-0.34%)
USD |
NYSE |
Nov 22, 16:00
13.36
0.00 (0.00%)
After-Hours: 16:44
Elanco Animal Health Revenue (Quarterly): 1.03B for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.03B |
| June 30, 2024 | 1.184B |
| March 31, 2024 | 1.205B |
| December 31, 2023 | 1.035B |
| September 30, 2023 | 1.068B |
| June 30, 2023 | 1.057B |
| March 31, 2023 | 1.257B |
| December 31, 2022 | 985.00M |
| September 30, 2022 | 1.026B |
| June 30, 2022 | 1.175B |
| March 31, 2022 | 1.226B |
| December 31, 2021 | 1.112B |
| September 30, 2021 | 1.131B |
| June 30, 2021 | 1.279B |
| March 31, 2021 | 1.242B |
| Date | Value |
|---|---|
| December 31, 2020 | 1.137B |
| September 30, 2020 | 890.00M |
| June 30, 2020 | 586.00M |
| March 31, 2020 | 658.00M |
| December 31, 2019 | 787.00M |
| September 30, 2019 | 771.30M |
| June 30, 2019 | 781.60M |
| March 31, 2019 | 731.10M |
| December 31, 2018 | 799.30M |
| September 30, 2018 | 761.10M |
| June 30, 2018 | 770.20M |
| March 31, 2018 | 736.20M |
| December 31, 2017 | 754.30M |
| September 30, 2017 | 697.10M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
586.00M
Minimum
Jun 2020
1.279B
Maximum
Jun 2021
1.054B
Average
1.09B
Median
Revenue (Quarterly) Benchmarks
| Pfizer Inc | 17.70B |
| Edwards Lifesciences Corp | 1.354B |
| Edgewise Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 2.441M |
| Palatin Technologies Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 364.00M |
| Total Expenses (Quarterly) | 1.035B |
| EPS Diluted (Quarterly) | 0.73 |
| Enterprise Value | 10.49B |
| Gross Profit Margin (Quarterly) | 52.23% |
| Profit Margin (Quarterly) | 35.34% |
| Earnings Yield | 3.00% |
| Operating Earnings Yield | 3.83% |
| Normalized Earnings Yield | -1.178 |